A proposal and prototype for a Research Risk Repository to improve the protection of research participants

Abstract

Background Accurate and consistent risk assessment is vital for the protection of research participants. Yet, current evaluation of the risks of research interventions often does not take into account the relevant empirical data. This approach raises concern that current practice may not be protecting research participants adequately, or that it may be thwarting acceptable research.

Purpose To propose and evaluate the possibility of creating and maintaining a Research Risk Repository which would make empirical data on the risks of research interventions available to institutional review boards, investigators, funders, and others.

Methods Analysis of the usefulness of a Research Risk Repository and evaluation of whether currently available empirical data are sufficient to establish such a repository.

Results Creation of a Research Risk Repository would provide a vital resource for systematically and accurately evaluating the risks of biomedical research. Realizing this goal requires data that have at least 4 characteristics: (1) trustworthy: to ensure credibility to all stakeholders; (2) robust: to support confident risk determinations; (3) inclusive: to cover all potential harms of the interventions under review; and (4) comprehensive: to determine which factors influence the risks of the interventions under review. Evaluation of existing data reveals that they satisfy these requirements for only a few research interventions and, even in those cases, only to a limited extent. Gaps in the currently available evidence highlight the need for systematic collection and maintenance of data on the risks posed by research interventions.

Limitations Creation and maintenance of a Research Risk Repository would be costly and require regular updating as new data are collected, and new practices and interventions emerge.

Conclusions A Research Risk Repository has the potential to significantly improve the consistency and accuracy of the evaluation of research risks. However, currently available data are generally insufficient for this purpose. Future collection and maintenance of data on the risks posed by research interventions will help to ensure that research participants receive appropriate protection and promote important research consistent with adequate subject protection.

Get full access to this article

View all access options for this article.

References

Slovic

. Perception of risk. Science 1987; 236: 280–285.

Tversky

Kahneman

. Judgment under Uncertainty: heuristics and biases. Science 1974; 185: 1124–1131.

Weinstein

. Optimistic biases about personal risks. Science 1989; 246: 1232–1233.

Slovic

. The perception of risk. Risk Soc Policy Ser 2000; 37: 473.

Shah

Whittle

Wilfond

. How do institutional review boards apply the federal risk and benefit standards for pediatric research JAMA 2004; 291: 476–482.

Lenk

Radenbach

Dahl

. Non-therapeutic research with minors: how do chairpersons of German research ethics committees decide J Med Ethics 2004; 30: 85–87.

van Luijn

Aaronson

Keus

. The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: acase study. J Med Ethics 2006; 32: 170–176.

Levine

. Ethics and Regulation of Clinical Research. Baltimore: Urban& Schwarzenberg, 1986.

Boulton

. Evidence-based criteria for the care and selection of blood donors, with some comments on the relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transfus Med 2008; 18: 13–27.

10.

Brenner

Doll

Goodhead

. Cancer risks attributable to low doses of ionizing radiation: assessing what we really know. Proc Natl Acad Sci USA 2003; 100: 13761–13766.

11.

Wilson

. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927; 22: 209–212.

12.

Valyasevi

Maddox

. Systemic reactions to allergy skin tests. Ann Allergy Asthma Immunol 1999; 83: 132–136.

13.

Lin

Tanner

Lynn

. Nonfatal systemic allergic reactions induced by skin testing and immunotherapy. Ann Allergy 1993; 71: 557–562.

14.

Turkeltaub

Gergen

. The risk of adverse reactions from percutaneous prick-puncture allergen skin testing, venipuncture, and body measurements: data from the second National Health and Nutrition Examination Survey 1976-80 (NHANES II). J Allergy Clin Immunol 1989; 84: 886–890.

15.

Codreanu

Moneret-Vautrin

Morisset

. The risk of systemic reactions to skin prick-tests using food allergens: CICBAA data and literature review. Eur Ann Allergy Clin Immunol 2006; 38: 52–54.

16.

Devenney

Falth-Magnusson

. Skin prick tests may give generalized allergic reactions in infants. Ann Allergy Asthma Immunol 2000; 85: 457–460.

17.

Reid

Lockey

Turkeltaub

. Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993; 92: 6–15.

18.

Bernstein

Wanner

Borish

. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2004; 113: 1129–1136.

19.

Lockey

Benedict

Turkeltaub

. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol 1987; 79: 660–677.

20.

Rid

Emanuel

Wendler

. Evaluating the risks of clinical research. JAMA 2010; 304: 1472–1479.

21.

The Cochrane Collaboration. Cochrane handbook forsystematic reviews of interventions (Version 5.1.0, March 2011) 2011. Available at: http://www.cochrane.org/training/cochrane-handbook (accessed 20 June 2011).

22.

National Institutes of Health. NIH budget 2011. Available at: http://www.nih.gov/about/budget.htm (accessed 20 June 2011).

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

1.27 MB

0.51 MB